Chicago, IL (PRWEB) November 07, 2016
The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services – held its North American Educational Forum on Lymphoma from October 28-30, 2016, at the Palmer House Hilton in Chicago, Illinois. This two-and-a-half-day program represented the most comprehensive lymphoma-specific educational conference in North America, providing critical information on treatment options, patient support issues, clinical trials and the latest advances in lymphoma research to people with lymphoma and their loved ones.
More than 400 patients, caregivers, and their loved ones registered for the 2016 Educational Forum, which was held in Chicago for the first time to provide education and support to lymphoma patients throughout the Midwest, and around the country, from some of the world’s leading lymphoma experts. This year’s Educational Forum was co-chaired by LRF’s Scientific Advisory Board Chair-elect Thomas M. Habermann, MD, Professor of Medicine at the Mayo Clinic College of Medicine at Rochester and LRF Scientific Advisory Board member Sonali M. Smith, MD, Associate Professor, Section of Hematology / Oncology, Director of the Lymphoma Program at the University of Chicago Medicine.
“As a Chicago lymphoma thriver, I understand first-hand how important it is for the Lymphoma Research Foundation to host its annual North American Educational Forum on Lymphoma here in the Windy City,” said Michael Werner, Chair of the Lymphoma Research Foundation’s Board of Directors. “The Educational Forum provides a unique opportunity to learn about lymphoma and its treatment from some of the world’s leading experts in the disease, ask questions about your specific type of lymphoma and meet others who have the same type of lymphoma as you. This program can be life-changing for so many and I am grateful that the Foundation was able to bring this unique educational opportunity to Chicago this year. Given the promise of the research discussed that this year’s Ed Forum, I believe that we can functionally cure most types of lymphoma within the next decade if we adequately fund our brilliant scientists.”
The 2016 North American Educational Forum on Lymphoma included disease-specific breakout sessions, expert panel presentations, treatment updates, and unique networking opportunities to those affected by lymphoma at no cost.
“Reaching all those impacted by a lymphoma diagnosis is a priority of the Lymphoma Research Foundation,” said Meghan Gutierrez, LRF Chief Executive Officer. “As incidence rates of lymphoma continue to rise in the Midwest, it is important for the Lymphoma Research Foundation to expand its reach with the National Educational Forum on Lymphoma – the largest program of its type in the United States – to the lymphoma community, providing access to the latest information on lymphoma treatment options and clinical research.”
This year’s North American Educational Forum on Lymphoma was supported by unrestricted educational grants from National Presenting Supporter Genentech | Biogen, National Platinum Supporter Celgene, National Gold Supporters AbbVie, Gilead Sciences, Pharmacyclics LLC, an AbbVie company, Janssen Biotech, Inc., and Teva Pharmaceuticals, National Silver Supporters Bayer, Seattle Genetics and Takeda Oncology, and National Bronze Supporters Adaptive Biotechnologies, Bristol-Myers Squibb, Idera Pharmaceuticals, Infinity Pharmaceuticals, Jazz Pharmaceuticals, Juno Therapeutics, Kite Pharmaceuticals, Merck and Novartis. For more information on the Lymphoma Research Foundation’s North American Educational Forum on Lymphoma, visit lymphoma.org/EdForum.
About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded nearly $60 million in lymphoma-specific research.
For additional information on LRF’s research, education and services, visit lymphoma.org.